...BRCA1/2 mutation carriers and controls), an international team investigating screening and diagnosis for men with a gene...
...BRCA1 C-terminal domain, a structural motif that has been shown to facilitate protein-protein interactions, suggesting t...
...BRCA1 expression and cleavage, accompanied with increases of the full-length BRCA1 and BRCA1 nuclear foci. In contrast, ...
To determine whether basal-like phenotype and vimentin and/or laminin are related in both sporadic/familial (BRCA1 or BR...
...BRCA1 in cancer cells. Here, we report that multiple E2Fs and associated factors bind the BRCA1 promoter at two adjacent...
...BRCA1 mutation to a patient's relative, who is at 50% risk? Case 4: Do we have an obligation to reveal that a patient is...
...BRCA1, BRCA2 and non-BRCA1/2 gene mutations. We detected 9 out of 80 familial tumors with this amplicon by chromosomal c...
...BRCA1/2 mutation, who fulfilled criteria for DNA testing. We developed a checklist for assessing risk communication and ...
Women who are at increased risk for breast and ovarian cancers, especially BRCA1 and BRCA2 mutation carriers, face a myr...
The optimal clinical management of breast cancer (BC) arising in BRCA1/2 mutations carriers is a difficult issue complic...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
